Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Huapont Life Science CoSZSE:002004 -0.23%65 EBITDA Margin % is 22.45% as of Jun. 2026, which is 9% above its 10-year median of 20.57. GuruFocus rates SZSE:002004 with a GF Score™ of 65/100 and a GF Value™ of ¥4.43 (Fairly Valued). The stock has 6 warning signs investors should review. Among 250 Agriculture companies, Huapont Life Science Co ranks better than 63.2% on this metric.
Huapont Life Science Co (SZSE:002004) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Huapont Life Science Co EBITDA Margin % Related Terms
Huapont Life Science Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SZSE:002004 vs CTVA, CF, MOS: EBITDA Margin % Comparison
For the Agricultural Inputs subindustry, Huapont Life Science Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Huapont Life Science Co EBITDA Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Huapont Life Science Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Huapont Life Science Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huapont Life Science Co (SZSE:002004) has a EBITDA Margin % of 22.45% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Huapont Life Science Co and its competitors. This is near median its historical median of 20.57. Over the past decade, Huapont Life Science Co's EBITDA Margin % has ranged from 9.93 to 23.01. According to the industry distribution chart, Huapont Life Science Co ranks #92 out of 250 companies in the Agriculture industry, placing it in the top 36.8%.
Is Huapont Life Science Co's EBITDA Margin % too high?
Huapont Life Science Co's current EBITDA Margin % of 22.45% is near median its 10-year median of 20.57. Over the past 10 years, this metric has ranged from a low of 9.93 to a high of 23.01. The Agriculture industry median EBITDA Margin % is 9.04. Huapont Life Science Co's value of 22.45% is 148.5% above this industry median. Based on the distribution chart, Huapont Life Science Co ranks #92 out of 250 companies in the Agriculture industry, which is above the industry midpoint. Overall, Huapont Life Science Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Huapont Life Science Co's EBITDA Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Huapont Life Science Co ranks #92 out of 250 companies for EBITDA Margin %. This puts Huapont Life Science Co in the upper half of its industry. The industry median EBITDA Margin % is 9.04. Huapont Life Science Co's value of 22.45% is 148.5% above this benchmark. Historically, Huapont Life Science Co's own EBITDA Margin % has ranged from 9.93 to 23.01 over the past decade. While the company's 10-year median is 20.57 vs. the industry median of 9.04, Huapont Life Science Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Agriculture company?
The median EBITDA Margin % among Agriculture companies is 9.04, based on 250 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Huapont Life Science Co's current EBITDA Margin % of 22.45% is 148.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Huapont Life Science Co and its competitors. For the Agriculture industry, the median EBITDA Margin % is 9.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huapont Life Science Co's current EBITDA Margin % is 22.45%, which is near median its own 10-year median of 20.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huapont Life Science Co stock overvalued right now?
Based on GuruFocus' analysis, Huapont Life Science Co (SZSE:002004) is currently considered Fairly Valued. The stock's GF Value™ is ¥4.43, compared to a current price of ¥4.38 — trading 1.1% below its estimated fair value. The current EBITDA Margin % is 22.45%, which is near median its 10-year median of 20.57 and 148.5% above the Agriculture industry median of 9.04. Huapont Life Science Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Huapont Life Science Co (SZSE:002004), the current EBITDA Margin % is 22.45% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huapont Life Science Co (SZSE:002004) Overvalued in 2026?
Based on GuruFocus' analysis, Huapont Life Science Co stock appears to be undervalued.
The current stock price of ¥4.38 is trading 1.1% below its estimated GF Value™ of ¥4.43.
GuruFocus considers Huapont Life Science Co to be Fairly Valued.
Key valuation signals for SZSE:002004:
EBITDA Margin %: 22.45% (near median its 10-year median of 20.57)
GF Value™: ¥4.43 vs. price of ¥4.38 (1.1% below fair value)
Industry Position: 148.5% above the Agriculture median (#92 of 250)
No single metric tells the full story. See the SZSE:002004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
65GF Score
Get the complete analysis for SZSE:002004
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002004 has been successfully added to your 
